Veterinary World

     Open access and peer reviewed journal  

ISSN (Online): 2231-0916


Home l Editorial board l Instructions for authors l Reviewer guideline l Open access policy l Archives l FAQ

Open Access

Copyright: The authors. This article is an open access article licensed under the terms of the Creative Commons Attribution License

( which permits unrestricted use, distribution and reproduction in any medium, provided the work is properly cited.

Research (Published online: 31-10-2015)

17. Evaluation of Spirulina platensis extract as natural antivirus against foot and mouth disease virus strains (A, O, SAT2) - Hind M. Daoud and Eman M. Soliman

Veterinary World, 8(10): 1260-1265



   doi: 10.14202/vetworld.2015.1260-1265


Hind M. Daoud: Department of Foot and Mouth, Veterinary Serum and Vaccine Research Institute, Abbassia, Cairo, Egypt;

Eman M. Soliman: Central Laboratory for Evaluation of Veterinary Biologics, Abbassia, Cairo, Egypt;

Received: 22-05-2015, Revised: 05-09-2015, Accepted: 15-09-2015, Published:31-10-2015


Corresponding author: Eman M. Soliman, e-mail:

Citation: Daoud HM, Soliman EM (2015) Evaluation of Spirulina platensis extract as natural antivius against foot and mouth disease virus strains (A, O, SAT2), Veterinary World 8(10): 1260-1265.

Aim: This work was aimed to document the antiviral activates of Spirulina platensis extract against foot and mouth disease virus (FMDV) different types to evaluate its replication in Baby Hamster Kidney (BHK) cell culture and in baby mice.

Materials and Methods: Cytotoxicity assay studied for S. platensis extract on BHK cells to determine the non-toxic dose. The non-toxic dose of Spirulina extract was mixed with each type of FMDV (A, O, SAT2). Then 10-fold dilutions from each mixture were done. FMDV titer for each type of treated FMDV was calculated to evaluate the antiviral activity of the Spirulina extract against FMDV. Furthermore, old baby Swiss mice were inoculated with 0.1 ml intraperitonially from the mixture of FMDV different types and different concentration of Spirulina extracts. After 48 h post inoculation, all the baby mice examined to evaluate the antiviral action of Spirulina extract.

Results: The result showed that the non-toxic doses of S. platensis (50 ug/ml) revealed 35.7%, 28.5%, and 31% reductions in FMDV titers Type O, A, and SAT2 on BHK cells, respectively. The same non-toxic dose gave 50% of the inhibitory concentration in baby mice without cytotoxic effect.

Conclusion: This study confirmed the biological activity of the ethanol extract of S. platensis against FMDV Types O, A, and SAT2. From the results, S. platensis could be useful as antiviral lead to limitation of infection among animals during outbreaks but further studies need to evaluate the S. platensis on experimental or natural infected farm animals to establish the effective dose side affected period of treatment of S. platensis.

Keywords: antiviral, foot and mouth disease virus, Spirulina platensis.

1. Febles, C.I., Arias, A. and Gill-Rodriguez, M.C. (1995) In vitro study of antimicrobial activity in algae (Chlorophyta, Phaeophyta and Rhodophyta) collected from coast of Tenerife (in Spanish). Anu. Estud. Canarios, 34: 181-192.
2. Ely, R., Supriya, T. and NaaiK, C.G. (2004) Antimicrobial activity of marine organisms collected of the coast of South East India. J. Exp. Bio. Ecol., 309: 121-127.
3. Kumar, V., Tirumalai, P.S., Singh, A., Bhatnagar, A.K. and Shrivastava, J.N. (2013) Natural compounds from algae and Spirulina platensis & its antimicrobial activity. Indo Glob. J. Pharm. Sci., 3(3): 212-223.
4. Fujisawa, T., Narikawa, R., Okamoto, S., Ehira, S., Oshimura, H., Suzuki, I., Masuda, T., Mochimaru, M., Takaichi, S., Awai, K., Sekine, M., Horikawa, H., Yashiro, I., Omata, S., Takarada, H., Katano, Y., Kosugi, H., Tanikawa, S., Ohmori, K., Sato, N., Ikeuchi, M., Fujita, N. and Ohmori, M. (2010) Genomic structure of an economically important cyanobacterium, Arthrospira (Spirulina) platensis NIES-39. DNA Res. Adv., April;17(2):85-103
PMid:20203057 PMCid:PMC2853384
5. Karali, F. Arthrospira platensis. Bio203 University of Wisconsin-La Crosse, Web. 30 Oct. 2011
6. Moreira, L.M., Ribeiro, A.C., Duarte, F.A., Morais, M.G. and Soares, L.A.S. (2013) Spirulina platensis biomass cultivated in Southern Brazil as a source of essential minerals and other nutrients. Afr. J. Food Sci., 7(12): 451-455.
7. Yaakob, Z., Ali, E., Zainal, A., Mohamad, M. and Takriff, M.S. (2014) An overview: Biomolecules from microalgae for animal feed and aquaculture. J. Biol. Res. Thessaloniki, 21: 6.
PMid:25984489 PMCid:PMC4376511
8. Gheda, S.F., Khalil, M.A. and Gheida, S.F. (2013) In vitro and in vivo preliminary results on Spirulina platensis for treatment of impetigo: Topical cream application. Afr. J. Biotechnol., 12(18): 2498-2509.
9. Hetta, M., Mahmoud, R., El-Senousy, W., Ibrahim, M., El-Taweel, G. and Ali, G. (2014) Antiviral and antimicrobial activities of Spirulina platensis. World J. Pharm. Pharm. Sci., 3(6): 31-39.
10. Whitton, B.A., Potts, M., editors. (2000) The Ecology of Cyanobacteria in the Netherlands. Kluwer Academic Publishers, Dordrecht, Netherlands.
11. Mendes, R.F., Nobre, B.P., Cardoso, M.T., Peveira, A. and Palavra, A.F. (2003) Supercritical carbon dioxide extraction of compounds with pharmaceutical importance from microalgae. Inorg. Chim. Acta, 356: 328-334.
12. Ozdemir, G., Karabay, N.U., Dalay, C.M. and Pazarbasi, B. (2004) Antibacterial activity of volatile component and various extracts of Spirulina platensis. Phytother. Res., 18: 754-757.
13. Yakoot, M. and Salem, A. (2012) Spirulina platensis versus silymarin in thetreatment of chronic hepatitis C virus infection a pilot randomized, comparative clinical trial. BMC Gastroenterol., 12: 32.
PMid:22497849 PMCid:PMC3353193
14. Kulshreshtha, A., Zacharia, A.J., Jarouliya, U., Bhadauriya, P., Prasad, G.B. and Bisen, P.S. (1995) Spirulina in health care management. Curr. Pharm. Biotechnol., 9: 400-405.
15. Lee, E.H., Park, J.E., Choi, Y.J., Huh, K.B. and Kim, W.Y. (2008) A randomized study to establish the effects of Spirulina in type 2 diabetes mellitus patients. Nutr. Res. Pract., 2(4): 295-300.
PMid:20016733 PMCid:PMC2788188
16. Deng, R. and Chow, T.J. (2010) Hypolipidemic, antioxidant, and antiinflammatory activities of microalgae Spirulina. Cardiovasc. Ther., 28(4): e33-45.
PMid:20633020 PMCid:PMC2907180
17. Karkos, P.D., Leong, S.C., Karkos, C.D., Sivaji, N. and Assimakopoulos, D.A.P. (2011) Spirulina in clinical practice: Evidence-based human applications. Evid. Based Complement. Alternat. Med., 2011: 531053.
PMid:18955364 PMCid:PMC3136577
18. Depa, P.M., Dimri, U., Sharma, M.C. and Tiwari, R. (2012) Update on epidemiology and control of foot and mouth disease - A menace to international trade and global animal enterprise. Vet. World, 5(11): 694-704.
19. Grubman, M.J. (2005) Development of novel strategies to control foot-and-mouth disease marker vaccines and antivirals. Biologicals, 33: 227-234.
20. Deshpande, T.M. and Chaphalkar, S.R. (2013) Antiviral activity of plant extracts against FMDV in vitro a preliminary report. Int. J. Inst. Pharm. Life Sci., 3(4): ??? . International Journal of Institutional Pharmacy and Life Sciences 3(4): July-August 2013
21. Vagnozzi, A., Stein, D.A., Iversen, P.L. and Elizabeth, R. (2007) Inhibition of foot-and mouth disease virus infections in cell cultures with antisensemorphino oligomers. J. Virol., 81(21): 11669-11680.
PMid:17728223 PMCid:PMC2168802
22. Wachsman, M.B., Castilla, V. and Coto, C.E. (1998) Inhibition of foot and mouth disease virus (FMDV) uncoating by a plant-derived peptide isolated from Melia azedarach L leaves. Arch. Virol., 143(3): 581-90.
23. Saad, M.A.A. and Fawzy, H.G.I.V. Antiviral action of ribavirin on FOOT and mouth disease virus replication in cell culture and laboratory animals. 7th Veterinary Medicine- Zagazig Conference (21-23 July, 2004), Sharm EL-Sheikh.
24. Chungsamarnyart, N., Sirinarumitr, T., Chumsing, W. and Wajjawalku, W. (2007) In vitro study of antiviral activity of plant crude-extracts against the foot and mouth disease virus. Kasetsart. J., 41: 97-103.
25. Boseila, A.A.H. (2011) Preliminary in vitro study for using aqueous cinnamon extract against foot-and-mouth disease virus. New York Sci. J., 4(11): 59-63.
26. Boseila, A.A.H. and Hatab, E.M.A. (2011) Evaluation of the antiviral activity of sage leaves (Salvia officinalis) extract against foot-and-mouth disease virus. Agricultural Relations (FAR), Egypt, 3-5 October. p301-308.
27. Zarrouk, C. (1966) Contribution a l, etuded, unecyanophycee. Influence de divers facteurs physiques et chimiquessularcroissance et laphotosynthese de Spirulina maxima. Ph. D. Thesis, Universite de Paris, Paris.
28. Raoof, B., Kaushik, B.D. and Prasanna, R. (2006) Formulation of a low-cost medium for mass production of Spirulina. Biomass. Bioenergy, 30: 537-542.
29. Abd, E., Baky, H., Hanaa, E., Baz, K.F. and EL-Latife, S.A. (2013) Induction of sulfated polysaccharides in Spirulina platensisas response to nitrogen concentration and its biological evaluation. J. Aquac. Res. Dev., 5: 1.
30. Fayzunnessa, N., Morshed, A., Uddin, A., Parvin, A. and Saifur, R. (2011) In vivo study on the efficacy of hypoglycemic activity of Spirulina plantesis in long evan rats. Int. J. Biomol. Biomed., 1: 27-33.
31. Macpherson, I. and Stocher, M. (1962) Polyma transformation hamster cell clones, an investigation of gebetic factors affecting cell competence. Virology, 16: 147-151.
32. Walum, E., Strenberg, K. and Jenssen, D. (1990) Understanding Cell Toxicology: Principles and Pratice. Ellis Howood, New York. p97-1119.
33. Simões, C.M.O., Amoros, M. and Girre, L. (1999) Mechanism of antiviral activity of triter penoid saponins. Phytother. Res., 21: 317-325.
34. El-Baz, F.K., El-Senousy, W.M., El-Sayed, A.B., Kamel, M.M. In vitro antiviral and antimicrobial activities of Spirulina platensis. J. Appl. Pharm. Sci., 3(12): 052-056.
35. Richards, J.T., Kern, E.R., Glasgow, L.A., Overall, Jr., J.C., Frank Deign, E. and Hatch, M.T. (1978) Antiviral activity of extracts from marine algae. Antimicrob. Agents Chemother., 14(1): 24-30.
36. Barteling, S. and Vreeswijk, J. (1991) Development in foot-and-mouth disease vaccines. Vaccine, 9: 75-88.
37. Belsham, G.J. (1993) Distinctive features of foot and-mouth disease virus, a member of the picorna virus family; aspects of virus protein synthesis, protein processing and structure. Prog. Biophys. Mol. Biol., 60: 241-260.
38. Kasetsart, J. (2007) In vitro study of antiviral activity of plant crude-extracts against the foot and mouth disease virus. Nat. Sci., 41: 97-103.
39. Abdo, S.M., Hetta, M.H., El-Senousy, W.M., Salah El Din, R.A. and Ali, G.H. (2012) Antiviral activity of freshwater algae. J. Appl. Pharm. Sci., 2: 21-25.
40. Corona, A.H., Nieves, I., Meckes, M., Chamorro, M. and Barron, B.L. (2002) Antiviral activity of Spirulina maxima against herpes simplex virus type 2. Antiviral Res., 56: 279-285.
41. Hayashi, O., Katoh, T. and Okuwaki, Y. (1994) Enhancement of antibody production in mice by dietary Spirulina platensis. J. Nutr. Sci. Vitaminol., 40(5): 431-441.
42. Neekhra, S., Saraogi, R., Thakur, D. and Singh, N. (2014) Neurobiological activity of Spirulina platensis in mice. J. Med. Chem. Drug Discov., 5: 21-32.